Ultra-cheap Ozempic is coming. That’s a mixed blessing for Australians

In late 2029 and 2031, Australian patents for Ozempic will expire, opening the market to cheaper generics. The estimated half million Australians currently using weight loss drugs may soon access the medication for a fraction of current prices. This shift could transform weight loss treatments, though it also raises concerns about societal implications.

Read full article on The Age →

Summary by Glance · Original reporting by The Age